Multiplex immunofluorescence chemistries with ZEISS tissue multiplexing workflow

Bringing leading multiplex immunofluorescence chemistries together in one automated 8-channel imaging platform.

19 medicines in Sweden are under investigation in a major EMA inquiry

unless new evidence can be provided that they are up to standard.

Trender inom life science 2025 – Del 1 fetmaläkemedel

inför 2025. I dag: fetma.

“We need to keep investing in research and innovation”

Jenni Nordborg has worked for just over four years to highlight life science in Sweden. Her mandate as national coordinator ends in December 2022. ““Life scienc...

Medical device quality assurance

Recordings from ZEISS Quality Innovation Days.

Astra Zenecas vd Pascal Soriot om Kina: ”Väldigt öppet”

Astra Zenecas vd Pascal Soriot hyllade Kina som ”väldigt öppet” och ”välkomnande” under ett event i Peking i helgen.

Samuel Lagercrantz: Immunotherapy against cancer is still in its early stages

For more than 100 years, researchers have tried to target the body’s own immune system to fight cancer cells. They have occasionally been laughed at and ridicul...

Konsultbolag slås ihop – Scandinavian CRO och Qadvis blir Aurevia

Scandinavian CRO och Qadvis har nu bägge officiellt blivit en del av Aurevia, och tar därmed det nya bolagets namn.

GU Ventures AB

A new giant among our microscopes

Two technologies in one machine.

Faster development of reliable sample handling

Festo USA has collaborated with PerkinElmer to develop a compact sample handling solution for a global leader in manufacturing medical devices. Thanks to the cu...

“Unfortunately, we are not strong when it comes to conducting clinical trials”

The number of company-initiated clinical trials conducted in Sweden has been declining in recent years. In mid-March, a government inquiry was presented that ai...

Samuel Lagercrantz: A special kind of hellishness afflicts post-COVID patients

In addition to the disease itself those suffering from post-COVID have to deal with people who try to label them as hypochondriacs, writes Samuel Lagercrantz in an editorial.

Novo Nordisk ska spara 12 miljarder – tusentals jobb kapas

Novo Nordisk varslar 9 000 anställda som en del av en omstrukturering som ska spara motsvarande 12 miljarder kronor årligen.

The route to vaccines for everyone: “We did not just sit around and wait”

The pandemic was in full swing, and no one knew when or even if a vaccine would come. At that point, the Swedish Minister of Social Affairs called with a propos...

Studie: AI kan avslöja kommande demens

Ett nytt AI-program uppges kunna bedöma risken för framtida Alzheimersrelaterad demens – genom analys av personers tal.

Novo Nordisk invests billions in expanding its production capacity

Danish pharmaceutical company Novo Nordisk is making a major investment to develop and expand its production facility in Hillerød, north of Copenhagen. DKK 15.9...

WuXi AppTec, UK Ltd

The Swedish Research Council gets go-ahead for more long-term funding

Following a government decision, the Swedish Research Council will soon be able to approve ten-year grant periods for funding research infrastructure, which may...

The dock that “thinks” for itself

The world of bulk material handling seems straightforward at first glance: moving, filling, delivering. However, the art of dealing with a variety of different ...

Milstolpe nådd för Leqembi – Bioarctic kan casha in

Försäljningen av alzheimerläkemedlet Leqembi har nått sin första milstolpe, och därmed kan svenska Bioarctic på allvar börja skörda frukterna av sitt utvecklingsarbete.

”Information security must become part of the Swedish life science strategy”

Sweden needs knowledge security to stand strong in the global competition, writes Björn Ursing in an opinion article.

No longer afraid of the dentist.

Teaching robot with piezo technology

Mavatar AB